Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

colitis/diarreia

O link é salvo na área de transferência
Página 1 a partir de 41 resultados

Composite for Clostridium difficile diarrhea and pseudomembranous colitis

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a preventive and curative pharmaceutical composition for Clostridium difficile diarrhea and pseudomembranous colitis. 2. Description of the Prior Art For the cure of Clostridium difficile diarrhea and pseudomembranous

Treatment of antibiotic associated diarrhea

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with

Method of treating ulcerative colitis

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to a method of treating a mammalian creature, preferably a human, having ulcerative colitis or inflammation of the colon. The term "Inflammatory Bowel Disease" is a designation commonly used for two related, but distinct, chronic inflammatory conditions affecting the

Tannin formulation for treating GI spasms in a subject having Crohn's disease or ulcerative colitis

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND 1. Field of the Invention The teachings provided herein relate to methods of treating gastrointestinal spasms. 2. Description of Related Art Antispasmodics can be used to prevent spasms of the stomach, intestine, uterus, or urinary bladder. Gastrointestinal spasms, for example, can be

Methods of treating gastrointestinal spasms in a subject having Crohn's Disease or ulcerative colitis

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND 1. Field of the Invention The teachings provided herein relate to methods of treating gastrointestinal spasms. 2. Description of Related Art Antispasmodics can be used to prevent spasms of the stomach, intestine, uterus, or urinary bladder. Gastrointestinal spasms, for example, can be

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF INVENTION The present invention is directed to modulators of the TGR5 receptor useful in the treatment of TGR5 mediated diseases or disorders. Specifically, the invention is concerned with compounds and compositions thereof, which activate the TGR5 receptor, methods of treating diseases or

Capsules for oral preparations and capsule preparations for oral administration

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION 1. Background of the Invention This invention relates to capsules for preparations for oral administration and also to capsule preparations for oral administration using said capsules. More particularly, this invention relates to capsules being able to be administered orally

Fatty acid delivery system comprising a hydrolyzable bond

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This application claims benefit of international application PCT/GB94/00713, filed Nov. 17, 1994, published as WO95/13801 May 26, 1995. FIELD OF THE INVENTION This invention relates to an agent for use in food, dietary, and the like preparations, and to preparations, formulations and dietary

Oral rehydration solution containing indigestible oligosaccharides

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to an oral rehydration solution containing indigestible oligosaccharides for the inhibition of disease states associated with Clostridium difficile. BACKGROUND OF INVENTION The successful management of acute diarrhea is still a challenge today. Acute

Inhibition of C. difficile infections by indigestible oligosaccharides

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to the use of indigestible oligosaccharides in the inhibition of disease states by Clostridium difficile. BACKGROUND OF INVENTION Clostridium difficile (C. difficile) is the leading known cause of nosocomial infections. Greenough et al., "Diarrhea in the

Method of binding and removing toxin A

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with

Treatment of C. difficile toxin B associated conditions

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns

Treatment of C. difficile toxin B associated conditions

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns

Treatment of C. difficile toxin B associated conditions

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns

Treatment of C. difficile toxin B associated conditions

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge